Two Sigma Advisers
ONCR

Two Sigma Advisers’s Oncorus, Inc. ONCR Stock Holding History

Two Sigma Advisers’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-75,712
Closed -$26.1K – 2746
2023
Q1 		$26.1K Sell
75,712
-23,488
-24% -$8.77K ﹤0.01% 2503
2022
Q4 		$25.1K Sell
99,200
-8,900
-8% -$5.06K ﹤0.01% 2415
2022
Q3 		$92K Sell
108,100
-42,600
-28% -$54.6K ﹤0.01% 2316
2022
Q2 		$190K Sell
150,700
-18,500
-11% -$25.1K ﹤0.01% 2288
2022
Q1 		$301K Buy
169,200
+126,800
+299% +$355K ﹤0.01% 2219
2021
Q4 		$223K Buy
+42,400
New +$328K ﹤0.01% 2248

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Two Sigma Advisers's ONCR Position: Q2 2023 in Review

Two Sigma Advisers sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 75,712 shares — an estimated $26.1K sold.

Two Sigma Advisers first reported a position in ONCR in Q4 2021 and held it in 6 quarters. The position peaked at $301K in Q1 2022. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Two Sigma Advisers reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 75,712 Oncorus, Inc. shares in Q2 2023, an estimated $26.1K.
  • Two Sigma Advisers first reported a position in Oncorus, Inc. in Q4 2021 and held it in 6 quarters.
  • Two Sigma Advisers's Oncorus, Inc. position peaked at $301K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.